Brief: Sedana Medical Proposes That No Dividend Is Paid For 2025
Feb 12 (Reuters) - Sedana Medical AB (publ) SEDANA.ST: Q4 SALES SEK 51.8 MILLION Q4 NET INCOME SEK -10.1 MILLION Q4 EBIT MARGIN -12% Q4 CASH FLOW FROM OPERATING ACTIVITIES SEK 200 THOUSAND Q4 ADJUSTED EPS SEK -0.1 THE BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND IS PAID FOR THE 2025 FINANCIAL YEAR Source text: ID:nMFN9Pr0Fz Further company coverage: SEDANA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln